Recombinant Varicella Zoster Virus gE (VZV gE) anticorps

N° du produit ABIN7482309

Cet anticorps anti- est un anticorps Human Monoclonal détectant dans ELISA. Adapté pour Varicella Zoster Virus (VZV).

Aperçu rapide pour Recombinant Varicella Zoster Virus gE (VZV gE) anticorps (ABIN7482309)

Antigène: Varicella Zoster Virus gE (VZV gE)

Type d'anticorp: Recombinant Antibody

Reactivité: Varicella Zoster Virus (VZV)

Hôte: Human

Clonalité: Monoclonal

Conjugué: Inconjugué

Application: ELISA

Classe de qualité: MALS verified

Clone: 1B10

Détail du produit

Fonction: Anti-Glycoprotein E (VZV) Antibody, Human IgG1 (1B10) (MALS verified)

Isotype: IgG1

Information d'application

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Stock: -20 °C

Détail du antigène

Antigène: Varicella Zoster Virus gE (VZV gE)

Autre désignation: VZV gE

Classe de substances: Viral Protein

Sujet: Varicella-zoster virus (VZV) is a neurotropic virus belonging to the Herpesviridae family. Primary VZV infection causes chickenpox and is followed by a life-long latent infection established mainly in the cranial and dorsal root ganglia. Reactivation of the virus is often associated with shingles (herpes zoster). Glycoprotein E (gE) is one of the known glycoproteins (gB, gC, gE, gH, gI, gK, gI) of VZV that is most abundantly expressed on the surface of virus and infected cells, playing an important role in viral replication and cell-to-cell spread. The strongly immunogenic gE can provide strong IgG signal in body fluid, which makes it ideal to be developed as an antigen for analysis of IgG antibodies. gE also demonstrates high potency as a vaccine immunogen and is formulated as the single viral envelope protein that constitutes the GSK VZV recombinant subunit vaccine Shingrix®.The antibody can reacte with gE specially.